Powerful stem cells made by reprogramming adult tissue could reduce the need for animal testing of new drugs, according to a scientific pioneer of the technology.
Jamie Thomson, of the University of Wisconsin, told The Times that â??in-vitro trialsâ? based on so-called induced pluripotent stem (IPS) cells would refine pharmaceutical development so that fewer animal experiments would be required.